• Health Systems

    Tech-enabling health systems to expand clinically validated care and monitoring beyond the hospital and clinic.

    We give physicians a convenient means to personalise mental health therapy for their patients at a time when wait times are peaking worldwide (OECD Waiting Times for Health Services, 2020). Dawn DTx adapts to the needs of every patient and provides objective, unbiased insights to reduce improve treatment decisions.

    Patient Testimonials

     

    "…I can accept negative thoughts better than before and I can practice meditation to calm me down if the day was really stressful. I found that when I practice meditation before I sleep, I can sleep better than before, and I don't wake up randomly in the middle of the night…"

     

     

    "…I learned to unwind and be more aware of my surroundings. After a stressful day, I looked forward to doing the meditation for at least 10 minutes and it helped me become stress-free and understanding of what is there around me..."

     

     

     

    "…I felt more calm and relaxed immediately after my 10 minute sessions. I am now able to pay more attention to my body and spot tense areas. The app also improved my focus on everyday tasks without getting distracted by other external things…"

     

  • What we offer
    ✓ Clinical resilience training at scale
    ✓ Intervention development
    ✓ Full backend integration enabling clinicians to leverage Dawn DTx data in clinical decision making
    ✓ Remote patient monitoring

    Interventions

    Scale clinical practices through digital integration within Dawn DTx.

    Licensing

    Personalise treatment regimens with objective quantification of wellbeing.

    Clinical Trials

    Deliver the latest in digital mental healthcare to patients.

     

  • Certifications

    Mobio Interactive’s digital therapeutic platform “Dawn DTx” has CE MDR Class 1, DCB 0129 ,and ISO 27001-2022 certification; and is GDPR-, HIPAA- and PHIPA-compliant.

    Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, Dawn DTx, Mobio has published over 20 peer-reviewed papers to date from over a dozen completed clinical studies.

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More